OBJECTIVE: The quality of documentation of signs and symptoms and validation of the diagnosis of irritable bowel syndrome (IBS) according to case definition criteria of Manning, Rome I and Rome II in an office setting has not been previously described. We sought to identify and validate cases of IBS based on the Manning, Rome I and Rome II diagnostic criteria in a rural practice setting. SETTING: Marshfield Epidemiologic Study Area (MESA) Central consisting of 14 ZIP codes in central Wisconsin, USA. METHODS: A retrospective cohort study involved 890 patients with the diagnostic codes 564.1 for irritable bowel syndrome and 306.4 spastic colon-psychogenic who had presented to the practice from 1993-2003. Duration, frequency, concordance and intensity of symptoms based on case definitions of IBS were abstracted from the medical records. RESULTS: During the study period, 890 incident cases of IBS were identified. Only 404 met one or more of the three diagnostic criteria, 340 (84%) met only the Manning criteria, 35 (10%) met only Manning and Rome I criteria, 4 (1%) met both Manning and Rome II criteria, and 25 (6%) met Manning and Rome I and Rome II criteria. Age adjusted incidence rates per 100,000 person-years for validated IBS cases during the observational period were 87 to 170 by Manning (lower confidence interval [CI]: 57-127, upper CI: 116-213), 8 to 34 (lower CI: 0-14, upper CI: 16-53) for Rome I and 3 to 16 (lower CI: 0-3, upper CI: 8-28) for Rome II. Comparison of Rome I and Rome II showed moderate concordance (kappa statistic = 0.51; 95% CI: 0.39-0.64). CONCLUSIONS: Only a small percentage of IBS cases with assigned diagnostic codes met case definition criteria for IBS. There were low concordance rates among the three diagnostic criteria applied.
OBJECTIVE: The quality of documentation of signs and symptoms and validation of the diagnosis of irritable bowel syndrome (IBS) according to case definition criteria of Manning, Rome I and Rome II in an office setting has not been previously described. We sought to identify and validate cases of IBS based on the Manning, Rome I and Rome II diagnostic criteria in a rural practice setting. SETTING: Marshfield Epidemiologic Study Area (MESA) Central consisting of 14 ZIP codes in central Wisconsin, USA. METHODS: A retrospective cohort study involved 890 patients with the diagnostic codes 564.1 for irritable bowel syndrome and 306.4 spastic colon-psychogenic who had presented to the practice from 1993-2003. Duration, frequency, concordance and intensity of symptoms based on case definitions of IBS were abstracted from the medical records. RESULTS: During the study period, 890 incident cases of IBS were identified. Only 404 met one or more of the three diagnostic criteria, 340 (84%) met only the Manning criteria, 35 (10%) met only Manning and Rome I criteria, 4 (1%) met both Manning and Rome II criteria, and 25 (6%) met Manning and Rome I and Rome II criteria. Age adjusted incidence rates per 100,000 person-years for validated IBS cases during the observational period were 87 to 170 by Manning (lower confidence interval [CI]: 57-127, upper CI: 116-213), 8 to 34 (lower CI: 0-14, upper CI: 16-53) for Rome I and 3 to 16 (lower CI: 0-3, upper CI: 8-28) for Rome II. Comparison of Rome I and Rome II showed moderate concordance (kappa statistic = 0.51; 95% CI: 0.39-0.64). CONCLUSIONS: Only a small percentage of IBS cases with assigned diagnostic codes met case definition criteria for IBS. There were low concordance rates among the three diagnostic criteria applied.
Authors: F Mearin; X Badía; A Balboa; E Baró; E Caldwell; M Cucala; M Díaz-Rubio; A Fueyo; J Ponce; M Roset; N J Talley Journal: Scand J Gastroenterol Date: 2001-11 Impact factor: 2.423
Authors: William D Chey; Kevin Olden; Eric Carter; John Boyle; Douglas Drossman; Lin Chang Journal: Am J Gastroenterol Date: 2002-11 Impact factor: 10.864
Authors: Lisa M Lix; Marina S Yogendran; Souradet Y Shaw; Laura E Targownick; Jennifer Jones; Osama Bataineh Journal: BMC Health Serv Res Date: 2010-02-01 Impact factor: 2.655
Authors: Triq Habib; Jamal T Hamdi; Waleed Hussain; Wail Almiamini; Khaled Hamdi; Abdul Majid Wani; Najah Rashid Al Zeyani Journal: BMJ Case Rep Date: 2010-09-19
Authors: M Nørgaard; D K Farkas; L Pedersen; R Erichsen; Z D de la Cour; H Gregersen; H T Sørensen Journal: Br J Cancer Date: 2011-02-22 Impact factor: 7.640
Authors: Chiara De Luca; Desanka Raskovic; Valeria Pacifico; Jeffrey Chung Sheun Thai; Liudmila Korkina Journal: Int J Environ Res Public Health Date: 2011-07-01 Impact factor: 3.390
Authors: Elaine F Harkness; Val Harrington; Sue Hinder; Sarah J O'Brien; David G Thompson; Paula Beech; Carolyn A Chew-Graham Journal: BMC Fam Pract Date: 2013-06-27 Impact factor: 2.497
Authors: Elaine F Harkness; Laura Grant; Sarah J O'Brien; Carolyn A Chew-Graham; David G Thompson Journal: BMC Fam Pract Date: 2013-12-02 Impact factor: 2.497